Outcomes of extracorporeal life support for low cardiac output syndrome after major cardiac surgery

Journal of Thoracic and Cardiovascular Surgery

Volumn 147, Issue 1, 2014, Pages 283-289

  Park, Sung Jun ^a   Kim, Joon Bum ^a   Jung, Sung Ho ^a   Choo, Suk Jung ^a   Chung, Cheol Hyun ^a   Lee, Jae Won ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; LACTIC ACID; NAFAMSTAT; NAFAMSTAT MESILATE; PROTAMINE SULFATE;

ACCURACY; ADULT; ANTICOAGULATION; AORTA SURGERY; AREA UNDER THE CURVE; ARTICLE; BLEEDING; BLOOD PH; BODY SURFACE; CARDIOPULMONARY BYPASS; DIABETES MELLITUS; DIALYSIS; EXTRACORPOREAL CIRCULATION; FEMALE; FOLLOW UP; FORWARD HEART FAILURE; GRAFT RECIPIENT; HEART ARREST; HEART INDEX; HEART SURGERY; HEART TRANSPLANTATION; HUMAN; HYPERTENSION; IMPLANTATION; INTESTINE ISCHEMIA; LACTATE BLOOD LEVEL; LACTIC ACIDOSIS; MAINTENANCE DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REOPERATION; SENESCENCE; SENSITIVITY AND SPECIFICITY; SURGICAL MORTALITY; SURVIVAL; TREATMENT OUTCOME;

25.1; 27; 41.1; ACT; ACTIVATED CLOTTING TIME; CARDIOPULMONARY BYPASS; CI; CONFIDENCE INTERVAL; CPB; ELCS; EXTRACORPOREAL LIFE SUPPORT; HAZARD RATIO; HEART TRANSPLANTATION; HR; HT; IABP; INTRA-AORTIC BALLOON PUMPING; LCOS; LOW CARDIAC OUTPUT SYNDROME; VAD; VENTRICULAR ASSIST DEVICE;

ADULT; AGED; ANTICOAGULANTS; AREA UNDER CURVE; BIOLOGICAL MARKERS; CARDIAC OUTPUT, LOW; CARDIAC SURGICAL PROCEDURES; CHI-SQUARE DISTRIBUTION; EXTRACORPOREAL CIRCULATION; FEMALE; GUANIDINES; HEART TRANSPLANTATION; HEPARIN; HUMANS; LACTIC ACID; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REOPERATION; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84890556108     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2012.11.006     Document Type: Article

References (25)

1. G.J. Magovern Jr., and K.A. Simpson Extracorporeal membrane oxygenation for adult cardiac support: the Allegheny experience Ann Thorac Surg 68 1999 655 661
2. S.M. Fiser, C.G. Tribble, A.K. Kaza, S.M. Long, R.K. Zacour, and J.A. Kern When to discontinue extracorporeal membrane oxygenation for postcardiotomy support Ann Thorac Surg 71 2001 210 214
3. A.J. Rastan, A. Dege, M. Mohr, N. Doll, V. Falk, and T. Walther Early and late outcomes of 517 consecutive adult patients treated with extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock J Thorac Cardiovasc Surg 139 2010 302 311
4. N. Doll, B. Kiaii, M. Borger, J. Bucerius, K. Krämer, and D.V. Schmitt Five-year results of 219 consecutive patients treated with extracorporeal membrane oxygenation for refractory postoperative cardiogenic shock Ann Thorac Surg 77 2004 151 157
5. M.Y. Wu, P.J. Lin, M.Y. Lee, F.C. Tsai, J.J. Chu, and Y.S. Chang Using extracorporeal life support to resuscitate adult postcardiotomy cardiogenic shock: treatment strategies and predictors of short-term and midterm survival Resuscitation 81 2010 1111 1116
6. R.A. Kloner, K. Przyklenk, and G.L. Kay Clinical evidence for stunned myocardium after coronary artery bypass surgery J Card Surg 9 1994 397 402
7. F.D. Pagani, K.D. Aaronson, F. Swaniker, and R.H. Bartlett The use of extracorporeal life support in adult patients with primary cardiac failure as a bridge to implantable left ventricular assist device Ann Thorac Surg 71 2001 S77 S81
8. Korean Network for Organ Sharing. Available from: http://www.konos.go.kr/ konosis/common/bizlogic.jsp.
9. S. Sakamoto, N. Taniguchi, S. Nakajima, and A. Takahashi Extracorporeal life support for cardiogenic shock or cardiac arrest due to acute coronary syndrome Ann Thorac Surg 94 2012 1 7
10. K.V. Meurs, K.P. Lally, G. Peek, and J.B. Zwischenberger Adult cardiac failure: management and use of ECLS B. Sarani, R.L. Kormos, Extracorporeal cardiopulmonary support in critical care III ed. 2005 Extracorporeal Life Support Organization Ann Arbor 468
11. D. Sidebotham, A. McGeorge, S. McGuinness, M. Edwards, T. Willcox, and J. Beca Extracorporeal membrane oxygenation for treating severe cardiac and respiratory failure in adults: part 2 - technical considerations J Cardiothorac Vasc Anesth 24 2010 164 172
12. L.A. Golding, R.D. Crouch, R.W. Stewart, R. Novoa, B.W. Lytle, and P.M. McCarthy Postcardiotomy centrifugal mechanical ventricular support Ann Thorac Surg 54 1992 1059 1064
13. N.G. Smedira, N. Moazami, C.M. Golding, P.M. McCarthy, C. Apperson-Hansen, and E.H. Blackstone Clinical experience with 202 adults receiving extracorporeal membrane oxygenation for cardiac failure: survival at five years J Thorac Cardiovasc Surg 122 2001 92 102
14. H. Thiele, U. Zeymer, F.J. Neumann, M. Ferenc, H.G. Olbrich, and J. Hausleiter Intraaortic balloon support for myocardial infarction with cardiogenic shock N Engl J Med 367 2012 1287 1296
15. Y.S. Chen, W.J. Ko, N.H. Chi, I.H. Wu, S.C. Huang, and R.J. Chen Risk factor screening scale to optimize treatment for potential heart transplant candidates under extracorporeal membrane oxygenation Am J Transplant 4 2004 1818 1825
16. D.D. Muehrcke, P.M. McCarthy, R.W. Stewart, S. Seshagiri, D.A. Ogella, and R.C. Foster Complications of extracorporeal life support systems using heparin-bound surfaces: the risk of intracardiac clot formation J Thorac Cardiovasc Surg 110 1995 843 851
17. Y. Hitomi, N. Ikari, and S. Fujii Inhibitory effect of a new synthetic protease inhibitor (FUT-175) on the coagulation system Haemostasis 15 1985 164 168
18. S. Fujii, and Y. Hitomi New synthetic inhibitors of C1r, C1 esterase, thrombin, plasmin, kallikrein and trypsin Biochim Biophys Acta 13 661 1981 342 345
19. K. Okajima, M. Uchiba, and K. Murakami Nafamosta mesilate Cardiovasc Drugs Rev 13 1995 51 65
20. S.J. Han, H.S. Kim, K.I. Kim, S.M. Whang, K.S. Hong, and W.K. Lee Use of nafamostat mesilate as an anticoagulant during extracorporeal membrane oxygenation J Korean Med Sci 26 2011 945 950
21. R.L. Bick Hemostasis defects associated with cardiac surgery prosthetic devices and other extracorporeal circuits Semin Thromb Hemostasis 11 1985 249 280
22. D.A. Tice, G.E. Reed, R.H. Clauss, and M.H. Worth Hemorrhage due to fibrinolysis occurring with open heart surgery J Thorac Cardiovasc Surg 46 1963 673 679
23. J. Musial, S. Niewiarowski, D. Hershock, T.A. Morinelli, R.W. Colman, and L.H. Edmunds Jr. Loss of fibrinogen receptors from the platelet surface during simulated extracorporeal circulation J Lab Clin Med 105 1985 514 522
24. P. Gluszko, B. Rucinski, J. Musial, R.K. Wenger, A.H. Schmaier, and R.W. Colmn Fibrinogen receptors in platelet adhesion to surfaces of extracorporeal circuit Am J Physiol 252 1987 H615 H621
25. M. Murase, A. Usui, Y. Tomita, M. Maeda, T. Koyama, and T. Abe Nafamostat mesilate reduces blood loss during open heart surgery Circulation 88 5 Pt 2 1993 II432 II436